Top Abstract Purchase Related
Home
>
Node
>
Subnode

Dimorphic (transitional-anaplastic) ductal cancer of the prostate

Samsonov, V.A.; Kolomoĭtsev, S.V.

Arkhiv Patologii 46(2): 71-73

1984

ISSN/ISBN: 0004-1955
PMID: 6324726
Document Number: 240036
Prostatic carcinoma of a specific structure with widespread metastasis in a 7 year-old patient who was treated with oestrogens and survived more than 4 years after the appearance of the first symptoms is described. Histologically in the primary tumour the combination of highly differentiated transitional-cell carcinoma (without cell degeneration and necrosis) and anaplastic, mainly small-cell carcinoma is found in the prostatic ducts. Pronounced degenerative and necrotic changes similar to those resulting from the oestrogen therapy with a positive effect are observed in the anaplastic carcinoma. Metastases had a structure of transitional-cell carcinoma.

Document emailed within 1 workday
Secure & encrypted payments

Blinov, N.N.; Kolosov, A.E. 1981: Clinical morphological characteristics of dimorphic lung cancer Voprosy Onkologii 27(2): 13-17
Yoshikawa, H.; Ikeuchi, T.; Onodera, Y.; Matsuda, N.; Sasaki, H.; Iguchi, H.; Kai, Y. 1994: A case of transitional cell carcinoma of the prostate Hinyokika Kiyo. Acta Urologica Japonica 40(3): 257-260
Bassi, P.; De Lisa, A.; Usai, P.; Pinto, F.; Sacco, E. 2005: Transitional cell carcinoma involvement of the prostate Annales d'Urologie 39(Suppl 5): S113-S119
Suzuki, K.; Sugaya, Y.; Ochi, M.; Hashimoto, S.; Tokue, A.; Ishikawa, S. 1999: A case of giant transitional cell carcinoma of the prostate Hinyokika Kiyo. Acta Urologica Japonica 45(2): 119-121
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Mottola, A.; Di Cello, V.; Lunghi, F.; Saltutti, C.; Natali, A.; Bianchi, S. 1991: Diagnostic, clinical and therapeutic aspects of primary transitional cell carcinoma of the prostate Minerva Urologica e Nefrologica 43(1): 37-39
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Ledent, C. 1996: Transgenic models of human thyroid pathologies: hyperfunctional adenoma, anaplastic cancer, differentiated cancer, hypothyroidism Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 151(2): 195-201
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Fayyad, L.M.; Al-Jader, K.M.; Al-Hawwari, B.A. 2006: Asynchronous adenoid cystic carcinoma of the prostate and transitional cell carcinoma of the urinary bladder Saudi Medical Journal 27(7): 1060-1062
Kamardin, L.N.; Romanchishen, A.F. 1982: Anaplastic cancer of the thyroid Voprosy Onkologii 28(2): 89-92
Kinkor, Z.; Skálová, A. 2005: Acinic cell-like differentiation in invasive ductal carcinoma and in ductal hyperplasia of the breast--report of two cases Ceskoslovenska Patologie 41(1): 29-33
Passoni, L.; Gallo, B.; Biganzoli, E.; Stefanoni, R.; Massimino, M.; Di Nicola, M.; Gianni, A.M.; Gambacorti-Passerini, C. 2006: In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomas Haematologica 91(1): 48-55